Ross Abrams to Biomarkers, Tumor
This is a "connection" page, showing publications Ross Abrams has written about Biomarkers, Tumor.
Connection Strength
0.256
-
Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels. Int J Radiat Oncol Biol Phys. 1999 Jul 15; 44(5):1039-46.
Score: 0.147
-
Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704. J Clin Oncol. 2008 Dec 20; 26(36):5918-22.
Score: 0.070
-
Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis. Cancer. 2010 Apr 01; 116(7):1674-80.
Score: 0.019
-
The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin Cancer Res. 2001 Dec; 7(12):4115-21.
Score: 0.011
-
Recurrent pancreatic adenocarcinoma: spiral CT evaluation following the Whipple procedure. Radiographics. 1997 Mar-Apr; 17(2):303-13.
Score: 0.008